Ikarian Capital
Latest statistics and disclosures from Ikarian Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ABVX, IONS, KOD, XBI, ALMS, and represent 33.28% of Ikarian Capital's stock portfolio.
- Added to shares of these 10 stocks: ABVX (+$75M), IONS (+$37M), MRNA (+$28M), RCUS (+$16M), COGT (+$14M), Newamsterdam Pharma Company (+$14M), CCCC (+$11M), QTTB (+$8.0M), VRDN (+$7.8M), PRAX (+$7.4M).
- Started 29 new stock positions in SLS, COGT, AMLX, HIMS, CLYM, CCCC, ABSI, IMUX, Quince Therapeutics, Newamsterdam Pharma Company.
- Reduced shares in these 10 stocks: TERN (-$140M), CYTK (-$82M), XBI (-$79M), QQQ (-$58M), IWM (-$50M), BMY (-$26M), RVMD (-$25M), HROW (-$17M), NVO (-$15M), KPTI (-$14M).
- Sold out of its positions in AMIX, BBOT, Centessa Pharmaceuticals, CYTK, DFTX, IOBTQ, Immunic, INSM, QQQ, IWM.
- Ikarian Capital was a net seller of stock by $-380M.
- Ikarian Capital has $927M in assets under management (AUM), dropping by -24.65%.
- Central Index Key (CIK): 0001778253
Tip: Access up to 7 years of quarterly data
Positions held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Ikarian Capital
Ikarian Capital holds 137 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Abivax Sa Sponsored Ads (ABVX) | 13.1 | $121M | +162% | 920k | 131.92 |
|
| Ionis Pharmaceuticals Call Option (IONS) | 6.0 | $56M | +192% | 700k | 79.29 |
|
| Kodiak Sciences (KOD) | 5.4 | $50M | -6% | 1.3M | 38.96 |
|
| Spdr Series Trust St Str Sp Biot Put Option (XBI) | 5.1 | $48M | -62% | 300k | 158.25 |
|
| Alumis (ALMS) | 3.7 | $35M | -17% | 1.2M | 28.14 |
|
| Praxis Precision Medicines I Com New (PRAX) | 3.4 | $31M | +30% | 94k | 334.79 |
|
| Moderna Put Option (MRNA) | 3.0 | $28M | NEW | 400k | 70.03 |
|
| Capricor Therapeutics Com New (CAPR) | 2.5 | $23M | +8% | 954k | 24.08 |
|
| Vaxcyte (PCVX) | 2.4 | $23M | -9% | 389k | 58.13 |
|
| Biosante Pharmaceuticals (ANIP) | 2.4 | $23M | -8% | 272k | 82.78 |
|
| Celldex Therapeutics Com New (CLDX) | 2.4 | $22M | +2% | 593k | 37.21 |
|
| Tenax Therapeutics Com New (TENX) | 1.8 | $17M | +4% | 1.2M | 14.55 |
|
| Vera Therapeutics Cl A (VERA) | 1.8 | $16M | +40% | 382k | 42.91 |
|
| Arcus Biosciences Incorporated (RCUS) | 1.7 | $16M | NEW | 505k | 30.83 |
|
| Relmada Therapeutics (RLMD) | 1.6 | $15M | -20% | 2.1M | 6.92 |
|
| Cogent Biosciences (COGT) | 1.5 | $14M | NEW | 370k | 38.70 |
|
| Newamsterdam Pharma Company Put Put Option | 1.5 | $14M | NEW | 400k | 33.89 |
|
| Contineum Therapeutics Cl A (CTNM) | 1.4 | $13M | 808k | 16.39 |
|
|
| C4 Therapeutics Com Stk (CCCC) | 1.2 | $11M | NEW | 2.4M | 4.67 |
|
| Maze Therapeatics (MAZE) | 1.2 | $11M | -3% | 379k | 29.84 |
|
| Arrowhead Pharmaceuticals (ARWR) | 1.2 | $11M | +140% | 138k | 81.51 |
|
| Biohaven (BHVN) | 1.2 | $11M | +81% | 748k | 14.88 |
|
| Connect Biopharma Hldgs SHS (CNTB) | 1.2 | $11M | -17% | 4.5M | 2.38 |
|
| Alto Neuroscience Com Shs (ANRO) | 1.2 | $11M | -20% | 407k | 26.39 |
|
| Pharvaris N V (PHVS) | 1.2 | $11M | -36% | 309k | 34.58 |
|
| Eyepoint Com New Call Option (EYPT) | 1.1 | $11M | 741k | 14.30 |
|
|
| Jade Biosciences Com New (JBIO) | 1.0 | $9.5M | -16% | 427k | 22.22 |
|
| Damora Therapeutics Com New (DMRA) | 0.9 | $8.7M | 336k | 26.01 |
|
|
| Q32 Bio (QTTB) | 0.9 | $8.0M | NEW | 630k | 12.74 |
|
| Miragen Therapeutics (VRDN) | 0.8 | $7.8M | NEW | 425k | 18.37 |
|
| Olema Pharmaceuticals (OLMA) | 0.8 | $7.3M | -49% | 583k | 12.51 |
|
| Pelthos Therapeutics Com Shs (PTHS) | 0.8 | $7.3M | 257k | 28.26 |
|
|
| Zura Bio Class A Ord Shs (ZURA) | 0.8 | $7.2M | +2% | 1.2M | 5.90 |
|
| Tectonic Therapeutic (TECX) | 0.8 | $7.1M | +30% | 206k | 34.38 |
|
| Spruce Biosciences Com New (SPRB) | 0.7 | $6.6M | 121k | 54.00 |
|
|
| Hims & Hers Health Com Cl A (HIMS) | 0.7 | $6.5M | NEW | 188k | 34.67 |
|
| Enliven Therapeutics (ELVN) | 0.7 | $6.4M | +51% | 127k | 50.75 |
|
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.7 | $6.4M | +129% | 3.4M | 1.86 |
|
| Bright Minds Biosciences Com New (DRUG) | 0.7 | $6.2M | -46% | 89k | 70.20 |
|
| Ovid Therapeutics (OVID) | 0.7 | $6.1M | -21% | 2.3M | 2.69 |
|
| Ocugen (OCGN) | 0.7 | $6.1M | 4.0M | 1.53 |
|
|
| Alpha Cognition Com New (ACOG) | 0.7 | $6.0M | -20% | 836k | 7.22 |
|
| Kymera Therapeutics Put Option (KYMR) | 0.6 | $5.8M | 50k | 114.67 |
|
|
| Harrow Health (HROW) | 0.6 | $5.8M | -74% | 136k | 42.47 |
|
| Kazia Therapeutics Sponsored Ads (KZIA) | 0.6 | $5.6M | NEW | 396k | 14.08 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.6 | $5.5M | -65% | 166k | 33.39 |
|
| Eupraxia Pharmaceuticals (EPRX) | 0.6 | $5.4M | -33% | 810k | 6.61 |
|
| Sellas Life Sciences Group I Com New Put Option (SLS) | 0.6 | $5.2M | NEW | 355k | 14.76 |
|
| Bioage Labs (BIOA) | 0.5 | $4.9M | NEW | 200k | 24.51 |
|
| Rezolute Com New (RZLT) | 0.5 | $4.9M | +5573% | 935k | 5.20 |
|
| Sionna Therapeutics Put Option (SION) | 0.5 | $4.7M | NEW | 108k | 43.99 |
|
| Monopar Therapeutics Com New (MNPR) | 0.5 | $4.4M | NEW | 48k | 92.59 |
|
| Bridgebio Pharma (BBIO) | 0.5 | $4.3M | -73% | 57k | 74.48 |
|
| Inventiva Sa Ads (IVA) | 0.4 | $4.2M | -20% | 1.1M | 3.68 |
|
| Absci Corp (ABSI) | 0.4 | $4.1M | NEW | 354k | 11.59 |
|
| Alector (ALEC) | 0.4 | $4.0M | -4% | 2.0M | 2.01 |
|
| Eliem Therapeutics (CLYM) | 0.4 | $3.9M | NEW | 300k | 13.04 |
|
| Fulcrum Therapeutics (FULC) | 0.4 | $3.8M | 1.0M | 3.66 |
|
|
| Cardiol Therapeutics Com Cl A (CRDL) | 0.4 | $3.5M | +22% | 3.3M | 1.06 |
|
| Cue Biopharma (CUE) | 0.4 | $3.3M | NEW | 104k | 31.56 |
|
| Cumberland Pharmaceuticals (CPIX) | 0.4 | $3.3M | -9% | 503k | 6.48 |
|
| Rein Therapeutics Com New (RNTX) | 0.3 | $3.1M | NEW | 3.0M | 1.04 |
|
| Arvinas Ord (ARVN) | 0.3 | $3.0M | 358k | 8.31 |
|
|
| Acumen Pharmaceuticals (ABOS) | 0.3 | $2.8M | 1.1M | 2.67 |
|
|
| Promis Neurosciences Com Shs (PMN) | 0.3 | $2.7M | +272% | 205k | 13.16 |
|
| Annexon (ANNX) | 0.3 | $2.5M | -25% | 430k | 5.71 |
|
| Bristol Myers Squibb Put Option (BMY) | 0.3 | $2.4M | -91% | 43k | 57.62 |
|
| Lexeo Therapeutics (LXEO) | 0.3 | $2.4M | 513k | 4.66 |
|
|
| Delcath Sys Com New (DCTH) | 0.3 | $2.3M | -56% | 186k | 12.59 |
|
| Adagio Therapeutics (IVVD) | 0.2 | $2.3M | 2.7M | 0.87 |
|
|
| Uniqure Nv Call Call Option | 0.2 | $2.3M | -85% | 50k | 46.06 |
|
| Cabaletta Bio (CABA) | 0.2 | $2.2M | -22% | 700k | 3.11 |
|
| Neumora Therapeutics (NMRA) | 0.2 | $2.2M | 1.3M | 1.70 |
|
|
| Amylyx Pharmaceuticals (AMLX) | 0.2 | $2.1M | NEW | 118k | 17.96 |
|
| Tarsus Pharmaceuticals (TARS) | 0.2 | $2.0M | 31k | 62.94 |
|
|
| Disc Medicine Call Option (IRON) | 0.2 | $1.9M | NEW | 27k | 73.14 |
|
| Silence Therapeutics Ads (SLN) | 0.2 | $1.8M | -4% | 831k | 2.20 |
|
| Journey Med Corp (DERM) | 0.2 | $1.8M | 251k | 7.08 |
|
|
| Dbv Technologies S A Sponsored Ads (DBVT) | 0.2 | $1.7M | 525k | 3.22 |
|
|
| Ibio Com New (IBIO) | 0.2 | $1.7M | 957k | 1.75 |
|
|
| Avalo Therapeutics Com New (AVTX) | 0.2 | $1.7M | -83% | 90k | 18.48 |
|
| Anteris Technologies Global (AVR) | 0.2 | $1.6M | -54% | 167k | 9.85 |
|
| Palisade Bio (PALI) | 0.2 | $1.6M | +172% | 750k | 2.09 |
|
| Amanat Acquisition Corp Cl A Ord | 0.2 | $1.5M | NEW | 150k | 10.16 |
|
| Kalaris Therapeutics (KLRS) | 0.2 | $1.5M | 360k | 4.07 |
|
|
| Quince Therapeutics | 0.1 | $1.3M | NEW | 72k | 18.19 |
|
| Lipocine Com New (LPCN) | 0.1 | $1.3M | 509k | 2.56 |
|
|
| Immunome (IMNM) | 0.1 | $1.3M | NEW | 60k | 21.19 |
|
| Elicio Therapeutics (ELTX) | 0.1 | $1.2M | NEW | 314k | 3.91 |
|
| Pliant Therapeutics (PLRX) | 0.1 | $1.1M | NEW | 1.0M | 1.14 |
|
| Immunic Com New (IMUX) | 0.1 | $1.0M | NEW | 68k | 15.37 |
|
| Quoin Pharmaceuticals Sponsored Ads (QNRX) | 0.1 | $1.0M | 212k | 4.84 |
|
|
| Equillium (EQ) | 0.1 | $971k | 304k | 3.20 |
|
|
| Neuronetics (STIM) | 0.1 | $912k | 701k | 1.30 |
|
|
| Faeth Therapeutics Com New (FTH) | 0.1 | $885k | +457% | 35k | 25.00 |
|
| Fractyl Health (GUTS) | 0.1 | $874k | 1.1M | 0.79 |
|
|
| Cybin Com New (HELP) | 0.1 | $874k | 132k | 6.61 |
|
|
| First Tracks Biotherapeutics Ord Shs (TRAX) | 0.1 | $861k | NEW | 43k | 20.12 |
|
| Verastem Com New (VSTM) | 0.1 | $817k | 214k | 3.82 |
|
|
| Direxion Shares Etf Trust Dai Bio Bea Etf (LABD) | 0.1 | $816k | 106k | 7.71 |
|
|
| Pepgen (PEPG) | 0.1 | $805k | -40% | 447k | 1.80 |
|
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $711k | 28k | 25.30 |
|
|
| CNS Pharmaceuticals (CNSP) | 0.1 | $649k | +196% | 136k | 4.78 |
|
| Lyell Immunopharma Com New (LYEL) | 0.1 | $577k | 41k | 14.05 |
|
|
| Wave Life Sciences SHS (WVE) | 0.1 | $496k | 85k | 5.81 |
|
|
| Immatics SHS (IMTX) | 0.1 | $492k | 49k | 10.13 |
|
|
| Passage Bio Com New (PASG) | 0.1 | $486k | +46% | 100k | 4.88 |
|
| Nextcure Com New (NXTC) | 0.0 | $461k | +20% | 288k | 1.60 |
|
| Forte Biosciences Com New (FBRX) | 0.0 | $446k | -82% | 21k | 21.25 |
|
| Solid Biosciences Com New (SLDB) | 0.0 | $429k | -83% | 43k | 9.99 |
|
| Traws Pharma Com New (TRAW) | 0.0 | $403k | -29% | 478k | 0.84 |
|
| Lexicon Pharmaceuticals Com New (LXRX) | 0.0 | $395k | 165k | 2.40 |
|
|
| Adlai Nortye Sponsored Ads (ANL) | 0.0 | $390k | 34k | 11.50 |
|
|
| Inmed Pharmaceuticals Com New (INM) | 0.0 | $380k | NEW | 245k | 1.55 |
|
| Viking Therapeutics (VKTX) | 0.0 | $379k | 9.7k | 39.01 |
|
|
| Macrogenics (MGNX) | 0.0 | $346k | 75k | 4.62 |
|
|
| Hyperliquid Strategies (PURR) | 0.0 | $236k | 30k | 7.87 |
|
|
| Evaxion As Sponsored Ads (EVAX) | 0.0 | $232k | 75k | 3.10 |
|
|
| Cartesian Therapeutics Com New (RNAC) | 0.0 | $217k | 21k | 10.42 |
|
|
| Compass Pathways Sponsored Ads (CMPS) | 0.0 | $212k | -97% | 15k | 14.15 |
|
| Neuphoria Therapeutics (NEUP) | 0.0 | $207k | 47k | 4.37 |
|
|
| Voyager Therapeutics (VYGR) | 0.0 | $186k | 53k | 3.50 |
|
|
| Vyne Therapeutics (VYNE) | 0.0 | $172k | 265k | 0.65 |
|
|
| BioCryst Pharmaceuticals (BCRX) | 0.0 | $168k | NEW | 17k | 10.00 |
|
| Enveric Biosciences Com Shs (ENVB) | 0.0 | $138k | NEW | 100k | 1.38 |
|
| Pmv Pharmaceuticals (PMVP) | 0.0 | $119k | 89k | 1.34 |
|
|
| Vistagen Therapeutics Ord (VTGN) | 0.0 | $117k | 519k | 0.23 |
|
|
| Chemomab Therapeutics Sponsored Ads (CMMB) | 0.0 | $84k | 52k | 1.62 |
|
|
| Nyxoah S A SHS (NYXH) | 0.0 | $80k | 47k | 1.69 |
|
|
| Airsculpt Technologies (AIRS) | 0.0 | $74k | 16k | 4.50 |
|
|
| Mangoceuticals Com New (MGRX) | 0.0 | $53k | 138k | 0.38 |
|
|
| Compass Therapeutics (CMPX) | 0.0 | $39k | 18k | 2.19 |
|
|
| Theriva Biologics Com New (TOVX) | 0.0 | $28k | 112k | 0.25 |
|
|
| Glucotrack Com New (GCTK) | 0.0 | $15k | 46k | 0.32 |
|
|
| Aethlon Med Com New (AEMD) | 0.0 | $12k | 14k | 0.82 |
|
|
| Jasper Therapeutics Com New (JSPR) | 0.0 | $10k | 24k | 0.42 |
|
|
| Biomx Com New (PHGE) | 0.0 | $6.8k | 20k | 0.35 |
|
Past Filings by Ikarian Capital
SEC 13F filings are viewable for Ikarian Capital going back to 2019
- Ikarian Capital 2026 Q2 filed Aug. 14, 2026
- Ikarian Capital 2026 Q1 filed May 15, 2026
- Ikarian Capital 2025 Q4 filed Feb. 18, 2026
- Ikarian Capital 2025 Q3 filed Nov. 14, 2025
- Ikarian Capital 2025 Q2 filed Aug. 14, 2025
- Ikarian Capital 2025 Q1 filed May 15, 2025
- Ikarian Capital 2024 Q4 filed Feb. 14, 2025
- Ikarian Capital 2024 Q3 filed Nov. 14, 2024
- Ikarian Capital 2024 Q2 filed Aug. 14, 2024
- Ikarian Capital 2024 Q1 restated filed May 17, 2024
- Ikarian Capital 2024 Q1 filed May 15, 2024
- Ikarian Capital 2023 Q4 filed Feb. 14, 2024
- Ikarian Capital 2023 Q3 filed Nov. 14, 2023
- Ikarian Capital 2023 Q2 filed Aug. 14, 2023
- Ikarian Capital 2023 Q1 filed May 15, 2023
- Ikarian Capital 2022 Q4 filed Feb. 14, 2023